Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHCPR mammography guidelines

This article was originally published in The Gray Sheet

Executive Summary

Will be used by FDA in its development of standards to implement the Mammography Quality Screening Act of 1992, according to agency staffers. The Agency for Health Care Policy and Research-funded panel developing the clinical practice guidelines recently held a public hearing in Bethesda, Maryland to gain input on the document. The guidance, entitled "Quality Determinants for Mammography," is expected to be finalized late this year.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000340

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel